Top Markets
Coin of the day
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
Clasificación en acciones #25706
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
Precio por acción
$2.09
Última sincronización: 2022-03-21
Capitalización bursátil
$47.04M
Cambio (1 día)
-0.48%
Cambio (1 año)
0.00%
País
US
Comercio Recro Pharma, Inc. (REPH)

Categoría

Historial de desdoblamientos de acciones de Recro Pharma, Inc. (REPH)
La acción Recro Pharma, Inc. (símbolo: REPH) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 21, 2026.
Una acción REPH comprada antes de Aug 21, 2026 equivaldría hoy a 0 acciones REPH.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
0 -
DE
0 -
DE
0 -
JP
0 -
CH
5 x119
IN